Skip to main content
Equibles
MDT logo

MDT · Medtronic plc · Metrics

Track MDT — free

Use MDT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$93.27 +0.88 (+0.95%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$120.46B
Shares
1.28B

MDT metrics

93 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$92.39
Market cap
$120.46B

Price action

20 metrics
Price change (1W)
+3.2%
Price change (30D)
+5.3%
Price change (3M)
+15.3%
Price change (6M)
+3.6%
Price change (YTD)
-2.0%
Price change (1Y)
+1.4%
Trailing year
Price change (5Y)
-30.1%
52-week high
$105.35
52-week low
$73.75
Change from 52-week high
-10.6%
Change from 52-week low
+27.7%
Annualized volatility
23.4%
Annualized volatility (3M)
27.1%
Beta
0.2
RSI (14D)
64.5
Price vs SMA 50
+8.6%
Price vs SMA 200
+5.0%
Avg volume (3M)
8.33M
Relative volume
1.1
Average dollar volume
$707.78M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
1.28B

Valuation

12 metrics
P / E (TTM)
23.2
Trailing earnings · reciprocal yield 4.3%
PEG ratio
0.6
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.2×
reciprocal yield 31.2%
P / book
2.4
reciprocal yield 41.7%
FCF yield
5.1%
TTM · current market cap
Buyback yield
1.0%
P / FCF
19.6
reciprocal yield 5.1%
P / operating cash flow
15.0
reciprocal yield 6.7%
Earnings yield
4.3%

Historical valuation

8 metrics
P / E historical average (3Y)
26.2×
reciprocal yield 3.8%
P / E historical average (5Y)
26.7×
reciprocal yield 3.7%
EV / revenue historical average (3Y)
3.9×
reciprocal yield 25.5%
EV / revenue historical average (5Y)
4.1×
reciprocal yield 24.5%
EV / EBIT historical average (3Y)
22.9×
reciprocal yield 4.4%
EV / EBIT historical average (5Y)
23.4×
reciprocal yield 4.3%
EV / EBITDA historical average (3Y)
15.8×
reciprocal yield 6.3%
EV / EBITDA historical average (5Y)
16.0×
reciprocal yield 6.2%

Dividends & buybacks

7 metrics
Dividend yield
3.0%
Trailing 12 months
Payout ratio
69.9%
Shareholder yield
4.0%
Dividend / share (TTM)
$2.85
Dividend growth YoY
+1.4%
Dividend growth streak
5
Last ex-dividend
2026-06-26

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-09-01

Profitability

9 metrics
Gross margin
—
Operating margin
18.1%
Trailing 12 months
Net margin
13.9%
Gross profit (TTM)
$19.49B
Operating profit (TTM)
$6.79B
Net income (TTM)
$5.22B
Trailing 12 months
Diluted EPS (TTM)
$4.06
FCF margin
16.3%
Effective tax rate
20.2%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$19.46

Growth

11 metrics
Revenue growth YoY
+13.7%
Year over year
Net income growth YoY
+41.3%
Revenue (TTM)
$37.54B
Trailing 12 months
EPS growth YoY
+40.7%
Shares change YoY
-0.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.2%
Revenue CAGR (5Y)
+3.8%
EPS CAGR (3Y)
+9.8%
EPS CAGR (5Y)
+7.0%
FCF CAGR (3Y)
+5.8%
FCF CAGR (5Y)
+2.1%

Quality

14 metrics
Return on equity
10.4%
Return on assets
5.6%
Debt / equity
—
Current ratio
2.1
EBITDA (TTM)
$9.72B
Free cash flow (TTM)
$6.13B
Quick ratio
1.5
Interest coverage
9.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.69B
Total assets
$93.31B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$8.04B
Capital expenditures (TTM)
$1.90B
R&D (TTM)
$2.92B
SG&A (TTM)
$12.18B
Stock compensation (TTM)
$496.00M
R&D / revenue
7.8%
Stock compensation / revenue
1.3%

Ownership (13F)

3 metrics
13F filers
2,117
13F filer change QoQ
-131
Institutional ownership
86.8%

Short interest

3 metrics
Short interest
1.1%
Latest settlement · 2.3 days to cover
Days to cover
2.3d
Short-squeeze score
44 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$257,931
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1613103 CUSIP G5960L103 13F (30d) 869 filings 813 filers Visit website Investor relations